{"id":"W2600807646","doi":"10.1007/s40262-017-0535-3","title":"Accounting for Pharmacokinetic Variability of Certolizumab Pegol in Patients with Crohn’s Disease","year":2017,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":false,"ca_institutions":"Robarts Clinical Trials","funders":"UCB Pharma","keywords":"Certolizumab pegol; Medicine; Pharmacokinetics; Crohn's disease; Disease; Internal medicine; Adalimumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003865841,0.0002531154,0.0003172919,0.00004240618,0.0001352533,0.00004354736,0.0006730471,0.0001285749,0.00005413417],"category_scores_gemma":[0.001696778,0.0002329813,0.0002061048,0.00003783883,0.0004250456,0.00001669092,0.0002784782,0.0001850312,0.000004367721],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001958743,"about_ca_system_score_gemma":0.0001929696,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003334407,"about_ca_topic_score_gemma":0.000004875995,"domain_scores_codex":[0.9978606,0.0001516936,0.0007778094,0.0005925104,0.0002373474,0.0003800451],"domain_scores_gemma":[0.9976832,0.000110026,0.0005269407,0.000981736,0.0004065646,0.0002915401],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.006982563,0.0008870386,0.9863241,0.0002169239,0.00007462699,0.00006569878,0.000007666959,0.0001315539,0.0006390159,0.0000264427,0.0007361533,0.003908234],"study_design_scores_gemma":[0.009721568,0.0001595299,0.9854369,0.00003990145,0.0001776626,5.120335e-7,0.000002181704,0.001124122,0.0006624406,0.0001244299,0.002257955,0.0002928359],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9971587,0.00002813634,0.00045346,0.0001492732,0.0004617116,0.001110107,0.0002256816,0.00001219141,0.0004007069],"genre_scores_gemma":[0.9984367,0.00003847868,0.0006217263,0.000157303,0.0004164668,0.0000827362,0.0001175857,0.0000497641,0.00007927141],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003615398,"threshold_uncertainty_score":0.9500702,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02272994562139833,"score_gpt":0.3501091740174944,"score_spread":0.3273792283960961,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}